NCT04073433View on ClinicalTrials.gov

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Psychological Effects of Study Drug

Interventions

DRUG

Midomafetamine HCl

120 mg midomafetamine HCl

BEHAVIORAL

Therapy

Non-directive therapy conducted during MDMA-assisted therapy session

Sponsors

Lead Sponsor

Lykos Therapeutics

All Listed Sponsors

lead

Lykos Therapeutics

INDUSTRY